Anna Molofsky and Shaeri Mukherjee were among the 22 early-career researchers in the 2017 class announced June 15 by The Pew Charitable Trusts.
Researchers at UCSF have found that older people with persistent pain show quicker declines in memory as they age and are more likely to have dementia years later.
UCSF researchers have drawn a link between genetic abnormalities in neurodegenerative diseases and the formation of RNA foci, work the scientists said may open avenues to the development of new drug treatments.
The UC Board of Regents have approved plans for three new UCSF building projects, including a new neuroscience building on the Mission Bay campus as well as a new psychiatry building and student housing in the nearby Dogpatch neighborhood.
Researchers made a significant advance, identifying the first “high-confidence” risk gene for Tourette disorder as well as three other probable risk genes.
Three UCSF faculty have been elected to the National Academy of Sciences, one of the highest honors accorded to American scientists.
A new trial may hold new hope for military personnel with PTSD and alcohol abuse through treatment with oxytocin, sometimes referred to as the “love hormone.”
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance of clinician scientists like UCSF’s Stephen Hauser who are working to transform research into cures for patients.
Christina Hueschen took home the top prize at this year’s UCSF Grad Slam competition for her talk titled “How to Build an Elephant.”
Neuroimaging is helping to distinguish between depression and dementia – two diseases with overlapping symptoms that can be difficult to diagnose properly.